REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical trials for REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Revolutionary cell therapy trial offers hope for untreatable autoimmune conditions

Disease control Not yet recruiting

This early-stage study is testing the safety of a new cell therapy for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy involves modifying immune cells to target specific markers on harmful B cells. Researchers will enroll 9 adults…

Matched conditions: REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS

Get alerted when new REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Revolutionary cell therapy trial offers hope for untreatable autoimmune conditions